Hikma to buy Roxane Labs for up to $2.65 billion
Permalink

Hikma to buy Roxane Labs for up to $2.65 billion

Drug maker Hikma Pharmaceuticals (LON:HIK) has bought US specialty generics company Roxane Laboratories from Boehringer…

Continue Reading →